Cantor Fitzgerald, L. P. Bio N Tech Se Transaction History

Cantor Fitzgerald, L. P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$88.96 - $112.35 $1.59 Million - $2.01 Million	17,899 New	17,899 $1.65 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $24,278 - $38,140	205 Added 7.15%	3,074 $461,000
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $366,227 - $525,342	2,869 New	2,869 $387,000
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $161,457 - $243,974	-1,310 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $165,387 - $303,723	1,310 New	1,310 $223,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.